Metals in Imaging of Alzheimer’s Disease
One of the hallmarks of Alzheimer’s disease (AD) is the deposition of amyloid plaques in the brain parenchyma, which occurs 7–15 years before the onset of cognitive symptoms of the pathology. Timely diagnostics of amyloid formations allows identifying AD at an early stage and initiating inhibitor th...
Main Authors: | Olga Krasnovskaya, Daniil Spector, Alexander Zlobin, Kirill Pavlov, Peter Gorelkin, Alexander Erofeev, Elena Beloglazkina, Alexander Majouga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/23/9190 |
Similar Items
-
Copper Coordination Compounds as Biologically Active Agents
by: Olga Krasnovskaya, et al.
Published: (2020-05-01) -
Pt(IV) Prodrugs with NSAIDs as Axial Ligands
by: Daniil Spector, et al.
Published: (2021-04-01) -
Posterior cortical atrophy: A rare variant of Alzheimer’s disease
by: Michael A. Meyer, et al.
Published: (2018-05-01) -
The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies
by: Luiz K. Ferreira, et al.
Published: (2014-12-01) -
Support vector machine-based classification of neuroimages in Alzheimer’s disease: direct comparison of FDG-PET, rCBF-SPECT and MRI data acquired from the same individuals
by: Luiz K. Ferreira, et al.
Published: (2017-10-01)